683Wire StoriesGS Wealth Issues Open Letter to Luckin Coffee’s Shareholders and Convertible Bondholders
Raises Concerns that Luckin’s Board is Seeking to Assist Centurium Capital in its Attempt to Take Voting Control Urges Shareholders and Convertible...
- 594Wire Stories
Toyoda Gosei Develops Full Color LED Vehicle Interior Lamps
Interior lighting accentuates the attractiveness of interior form and materials KIYOSU, Japan–(BUSINESS WIRE)–Toyoda Gosei Co., Ltd. (TOKYO:7282) has developed full color LED...
- 580Wire Stories
Seoul Viosys Provides Air Purifier Sterilizers, Which Dramatically Reduce the Risk of COVID-19 Infection, to 300 Small Businesses in Korea for Free
Seoul Viosys donates air purifying sterilizers and plays an important role in K-quarantine People have the right to breathe clean air as...
- 649News
It’s all in the mix, Sennheiser launches HD 400 PRO studio headphones
WEDEMARK, GERMANY – Media OutReach – 3 December 2021 – Audio specialist Sennheiser launches a new pair of professional headphones for mixing,...
- 685News
TÜV Rheinland Hosts Webinar Bringing Together Stakeholders to Address the Textile Microplastics Challenge
HONG KONG SAR – Media OutReach – 3 December 2021 – On 16 November, the international independent third-party testing, inspection and certification organization TÜV Rheinland...
- 673Wire Stories
BeiGene and EUSA Pharma Announce NMPA Approval of SYLVANT® (Siltuximab for Injection) in China for Idiopathic Multicentric Castleman Disease
CAMBRIDGE, Mass. & BEIJING & HEMEL HEMPSTEAD, England–(BUSINESS WIRE)–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160) and EUSA Pharma (UK), Ltd. today announced that...
- 716Wire Stories
BeiGene Announces Inclusion in the China National Reimbursement Drug List (NRDL) of Tislelizumab in Three New Indications, BRUKINSA® (Zanubrutinib) in One New Indication, and the First Listing for Pamiparib
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–BeiGene (NASDAQ:BGNE; HKEX:06160), a global science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment...
- 615Wire Stories
BeiGene and EUSA Pharma Announce NMPA Approval of SYLVANT® (Siltuximab for Injection) in China for Idiopathic Multicentric Castleman Disease
CAMBRIDGE, Mass. & BEIJING & HEMEL HEMPSTEAD, England–(BUSINESS WIRE)–BeiGene, Ltd. (NASDAQ:BGNE; HKEX:06160) and EUSA Pharma (UK), Ltd. today announced that the China...
- 587News
Capricorn Foundation: Stablecoin Is Making Waves in Traditional Economy
KUALA LUMPUR, MALAYSIA – Media OutReach – 3 December 2021 – Crypto has had futures for some times and only recently has its structure...
- 717News
AWS Announces AWS IoT TwinMaker
New service makes it faster and easier to create digital twins of real-world systems like buildings, factories, industrial equipment, and production lines—helping...
